INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

73,241 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
368.3K sh
Oct 28, 2026Oct 30, 2026
Page 168 of 1832
← PrevNext →
traded Oct 28, 2026
+2d
SEC Form 4

Evidence

9
MM
Martino Roxanne MDirector
VTRVentas, Inc.
Grant or award
A$1,500
18 sh
Oct 30, 2026Oct 30, 2026
traded Oct 30, 2026
+0dSEC Form 4

Evidence

9
VT
Vallejo Alejandro TEVP, Chief People Officer
PCGPG&E Corp
Tax withholding
F$13K
1,029 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
36.1K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
JJ
Jacobs Kevin JSee Remarks
HLTHilton Worldwide Holdings Inc.
Option exercise
M—
16.0K sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
82.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
JJ
Jacobs Kevin JSee Remarks
HLTHilton Worldwide Holdings Inc.
Option exercise
M—
31.1K sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

9
JJ
Jacobs Kevin JSee Remarks
HLTHilton Worldwide Holdings Inc.
Option exercise
M—
27.4K sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

9
HD
Hutcheson Stewart DDirector
IDCCInterDigital, Inc.
Grant or award
A—
47 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
JJ
Jacobs Kevin JSee Remarks
HLTHilton Worldwide Holdings Inc.
Option exercise
M—
29.1K sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
82.5K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
269.3K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
65.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
36.1K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
DA
Dianaty AliEVP Ch. Prod. & Tech Officer
MMEDMiniMed Group, Inc.
Tax withholding
F$8,500
449 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
133.1K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
82.5K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BR
Brezski RichardChief Financial Officer
IDCCInterDigital, Inc.
Grant or award
A—
31 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
269.3K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BJ
Baker JeffPrincipal Accounting Officer
CRWVCoreWeave, Inc.
Option exercise
M—
12.5K sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

9
VG
vant Hoff GrahamDirector
ANNAAleAnna, Inc.
Option exercise
M—
20.2K sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
824.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
48.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
133.1K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
JJ
Jacobs Kevin JSee Remarks
HLTHilton Worldwide Holdings Inc.
Option exercise
M—
12.8K sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

9
RF
Rankin Jean FDirector
IDCCInterDigital, Inc.
Grant or award
A—
2 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
GH
Gillman Joan HDirector
IDCCInterDigital, Inc.
Grant or award
A—
49 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
KJ
Kinsell JoshuaChief Accounting Officer
APPSDigital Turbine, Inc.
Tax withholding
F$6,532
618 sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
368.3K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
195.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

7
LA
Le-Quoc AlexisDirector, Chief Technology Officer
DDOGDatadog, Inc.
Open-market sale · 10b5-1 plan
SELL$1.57M
5,670 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

7
LA
Le-Quoc AlexisDirector, Chief Technology Officer
DDOGDatadog, Inc.
Open-market sale · 10b5-1 plan
SELL$3.17M
11.4K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

7
LA
Le-Quoc AlexisDirector, Chief Technology Officer
DDOGDatadog, Inc.
Open-market sale · 10b5-1 plan
SELL$2.87M
10.3K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

6
JW
Juvenal Tobin WChief Commercial Officer
CSTLCASTLE BIOSCIENCES INC
Open-market sale · 10b5-1 plan
SELL$44K
1,237 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

5
CL
Chen Lawrence LirenDirector, President and CEO
IDCCInterDigital, Inc.
Grant or award
A—
68 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

5
BW
Betz WilliamEVP & CFO
NXPINXP Semiconductors N.V.
Grant or award
A—
5,364 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

5
SD
Schmidt Joshua D.CLO & Corp Secretary
IDCCInterDigital, Inc.
Grant or award
A—
23 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

5
PR
Pankaj RajeshChief Technology Officer
IDCCInterDigital, Inc.
Grant or award
A—
34 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

5
RD
Ruppel DavidSVP & GM Transportation Bus.
LFUSLITTELFUSE INC /DE
Option exercise
M—
1,112 sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

5
MC
McDonough ClaireChief Financial Officer
RIVNRivian Automotive, Inc. / DE
Disposition to issuer
D—
730.3K sh
Oct 30, 2026Oct 30, 2026
traded Oct 30, 2026
+0dSEC Form 4

Evidence